In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline ...

“In patients with AF at low risk of stroke, anticoagulation with daily rivaroxaban does not ... of prescribing oral ...

Boston Scientific Corp. (BSX) announced positive three-year primary endpoint results from the OPTION global clinical trial of the ...

DOACs only and warfarin only are more likely to be prescribed to Medicare beneficiaries seeing clinicians in rural areas compared with urban areas.

Just 15% of patients have their filters taken out despite clear recommendations they should be removed as soon as feasible.

Cadrenal Therapeutics, Inc., (the "Company" or "Cadrenal"), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to provide safer and superior ...

"We look forward to partnering with the AC Forum and contributing to programs that advance safer, more effective care and inform about ongoing research and anticoagulation best practice guidelines." ...

According to NASS, the Clinical Guidelines were based on a strict analytical process which included a strength of the ...

A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with intermediate-risk ...

But on the other hand, there are concerns that if we start anticoagulation early, it could cause intracranial bleeding, including hemorrhagic transformation of the acute infarct. Guidelines on ...

Although the guidelines specifically address obstructive ... risk for stroke and guide the decision on whether to initiate anticoagulation therapy. “If you have a CHA 2 DS 2-VASc score of ...

"This finding came as a surprise, especially in light of the safety guidelines released by the FDA in 2010 and again in 2014, ...